Current Studies
Thanks for your interest!
Type 2 Diabetes at Increased Cardiovascular Risk
We are actively enrolling patients into this exciting study evaluating a new medication to treat type 2 diabetes and obesity. You may be eligible to enroll in the trial if you meet the following criteria:
- Have Type 2 Diabetes and overweight/obese with a BMI of 25 or greater
- Have an A1C > 7%
- Have risk factors for heart disease or strokes
- Meet other inclusion/exclusion criteria
Eligible patients who enroll in the trial will receive free medication, free assessments of your diabetes and heart disease risk factors and reimbursement for your time.
Cardiovasular
Have you considered participating in a clinical trial to learn more about your cardiovascular disease? To learn more, visit:
Type 2 Diabetes Mellitus – (Novo Nordisk)
We are actively enrolling patients in an exciting research study for patients with Type 2 Diabetes Mellitus. You may be eligible to participate if you meet the following criteria:
- 18 years old or older
- Have an A1C between 7 and 10.5%
- Have a BMI of 25 or greater
- Currently being treated with Metformin by itself or in combination with a SGLT2 inhibitor such as Jardiance, Farxiga, Invokana or Steglatro
Eligible patients who enroll in the study will receive free study medication, a free eye exam, free diabetes testing supplies, and reimbursement for time and travel.
Type 2 Diabetes Mellitus (Lilly)
Are you struggling with control of your Type 2 Diabetes? You may be eligible to participate in a research study involving a new medication to treat Type 2 Diabetes if you meet the following criteria:
- 18 years old or older
- Have a A1C between 7 and 10.5%
- Have a BMI 25 or greater
- Currently taking Metformin at a dose of at least 1500mg a day
Eligible patients who enroll will receive free study medication, free assessment of their diabetes and be reimbursed for their time.